DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20150644

C-peptide and cardiovascular system

Himmatrao S. Bawaskar, Parag Himmatrao Bawaskar, Pramodini Himmatrao Bawaskar

Abstract


Background: C-peptide and insulin are secreted by pancreatic beta cells in equimolar concentrations. C- Peptide is associated with increased risk of cardiovascular disease.

Methods: Routine outpatient department patients were investigated for serum C-peptide, Diabetes, Ischemic heart disease, hypertension and skin lesion acanthosis negrican.

Results: Total ninety five patients  enrolled in study of these peptide level 2, 2 to5 and >5 found in 22,46,27 patients respectively, with diabetes mellitus in 21 (95%), 39(55%) and 24 (89%), ischemic heart diseases 1(5%), 15(33%), 13(48%) , hypertension 9(41%), 20(44%), 12(45%), acanthosis negrican 9 (41%), 27 (59%), 21 (78%), family history 1 (5%), 18 (39%), 11 (41%) respectively.

Conclusion: Significant incidence of hypertension and ischemic heart disease is related to raised level of circulating C-peptide.


Keywords


C-peptide, Hypertension, DM, Ischemic heart disease, Acanthosis negrican

Full Text:

PDF

References


Toffolo G, De Grandi F, Cobelli C. Estimation of beta–cells sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modelling the secretion. Diabetes. 1995;44:845-54.

Wahren J, Ekberg k, Jornvall H. C-peptide is a bioactive peptide. Diabetologia. 2007;50(3):503-9.

Cotter MA, Ekberg K, Wahren J, Cameron NE. Effects of pro-insulin c-peptide in experimental diabetic neuropathy; vascular action and modulation by nitric oxide syntheses inhibition. Diabetes. 2003;52,1812-7.

Marx N, Walcher D, Raichle C, Aleksic M, Bach H et al. C-peptide localizes with macrophages in early atherosclerotic lesion of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Boil. 2004;24:540-5.

Chan WB, Tong PC, Chow CC, So Wy, Ng Mc et al. The associations of body mass index, c-peptide and metabolic status in chine’s type 2 diabetes patients. Diabetic Med. 2004;21:349-53.

Min JY, Min KB. Serum c-peptide levels and risk of death among adult without diabetes mellitus. CMAJ. 2013;185:e402-8.

Ghorbani A and Shafiee –Nick R. Pathological consequences of C-peptide deficiency in insulin dependent diabetes mellitus. World J Diabetes. 2015;15:145-50.

Forst T, De la, Tour DD et al. Effects of pro-insulin c-peptide on nitric oxide, micro vascular blood flow and erythrocyte NA+, K+-ATPase activity in diabetes mellitus type-1. Clin Sci (Lond). 2000;98:283-90.

Arslanian SA. Type 2 diabetes mellitus in children: Pathophysiology and risk factors. J Pediatric Endocrinol Metab. 2000;13:1385-93.

Higgins SP, Freemark M, Pose NS. Acanthosis negricans: a practical approach to evaluation and management. Dermatol online J. 2008;14:2.

Beckman JA, Creager MA, Libby P. Diabetes and Atherosclerosis: epidemiology, pathology, patho physiology and management. JAMA. 2002;287:2570-81.